384 related articles for article (PubMed ID: 27934592)
21. Generation of a human iPSC line from a patient with a defect of intergenomic communication.
Zurita F; Galera T; González-Páramos C; Moreno-Izquierdo A; Schneiderat P; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):120-3. PubMed ID: 27345795
[TBL] [Abstract][Full Text] [Related]
22. Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.
Varga E; Nemes C; Kovács E; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Nov; 17(3):514-516. PubMed ID: 27789401
[TBL] [Abstract][Full Text] [Related]
23. Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a patient with lymphedema-distichiasis syndrome (LDS) carrying an insertion-deletion complex mutation in the FOXC2 gene.
Itoh M; Kawagoe S; Okano HJ; Nakagawa H
Stem Cell Res; 2016 May; 16(3):611-3. PubMed ID: 27346194
[TBL] [Abstract][Full Text] [Related]
24. Generation of human iPSCs from urine derived cells of a non-affected control subject.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():33-36. PubMed ID: 28395799
[TBL] [Abstract][Full Text] [Related]
25. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
[TBL] [Abstract][Full Text] [Related]
26. Establishment of a human iPSC line (MUSIi007-A) from peripheral blood of normal individual using Sendai viral vectors.
Potirat P; Wattanapanitch M; Kheolamai P; Issaragrisil S
Stem Cell Res; 2018 Oct; 32():43-46. PubMed ID: 30172906
[TBL] [Abstract][Full Text] [Related]
27. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Dinnyés A; Kobolák J
Stem Cell Res; 2016 Nov; 17(3):482-484. PubMed ID: 27789399
[TBL] [Abstract][Full Text] [Related]
28. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):479-481. PubMed ID: 27789398
[TBL] [Abstract][Full Text] [Related]
29. Generation of a human induced pluripotent stem cell (iPSC) line from a Bernard-Soulier syndrome patient with the mutation p.Asn45Ser in the GPIX gene.
Lopez-Onieva L; Machuca C; Lamolda M; Montes R; Lozano ML; Vicente V; Rivera J; Ramos-Mejía V; Real PJ
Stem Cell Res; 2016 Nov; 17(3):603-606. PubMed ID: 27934591
[TBL] [Abstract][Full Text] [Related]
30. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
31. Generation of human iPSC line GRX-MCiPS4F-A2 from adult peripheral blood mononuclear cells (PBMCs) with Spanish genetic background.
Cabrera S; Ji AR; Frejo L; Ramos-Mejia V; Romero T; Real P; Lopez-Escamez JA
Stem Cell Res; 2015 Sep; 15(2):337-40. PubMed ID: 26284980
[TBL] [Abstract][Full Text] [Related]
32. Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.
Varga E; Nemes C; Bock I; Varga N; Fehér A; Kobolák J; Dinnyés A
Stem Cell Res; 2016 Nov; 17(3):463-465. PubMed ID: 27789394
[TBL] [Abstract][Full Text] [Related]
33. Derivation of human induced pluripotent stem cell (iPSC) line from a 79year old sporadic male Parkinson's disease patient.
Zhang S; Liu L; Hu Y; Lv Z; Li Q; Gong W; Sha H; Wu H
Stem Cell Res; 2017 Mar; 19():43-45. PubMed ID: 28413004
[TBL] [Abstract][Full Text] [Related]
34. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
35. Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells.
Maguire JA; Gagne AL; Jobaliya CD; Gandre-Babbe S; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):338-41. PubMed ID: 27345999
[TBL] [Abstract][Full Text] [Related]
36. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
37. Generation of human iPSCs from urine derived cells of patient with a novel heterozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2017 Jan; 18():41-44. PubMed ID: 28395801
[TBL] [Abstract][Full Text] [Related]
38. Generation of Hermansky-Pudlak Syndrome Type 1 (HPS1) induced pluripotent stem cells (iPSCs).
Maguire JA; Lu L; Mills JA; Sullivan LM; Gagne A; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):233-5. PubMed ID: 27345974
[TBL] [Abstract][Full Text] [Related]
39. Establishment of an induced pluripotent stem cell line (ZZUSAHi002-A) derived from peripheral blood mononuclear cells of a healthy individual.
Liu S; Niu S; Li Y; Xiong H; Li Y; Jian L; Zhang L
Stem Cell Res; 2020 Oct; 48():101966. PubMed ID: 32911326
[TBL] [Abstract][Full Text] [Related]
40. Generation of a human iPSC line from a patient with an optic atrophy 'plus' phenotype due to a mutation in the OPA1 gene.
Galera-Monge T; Zurita-Díaz F; Moreno-Izquierdo A; Fraga MF; Fernández AF; Ayuso C; Garesse R; Gallardo ME
Stem Cell Res; 2016 May; 16(3):673-6. PubMed ID: 27346197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
